Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall St set for muted open as tech wobble persists; Tesla gains
- Oil heads for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: TVRD) | Delayed: 1.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.07 | 52 Week High | $ | |||
| Open | $1.05 | 52 Week Low | $ | |||
| Day High | $1.07 | P/E | N/A | |||
| Day Low | $1.04 | EPS | $ | |||
| Volume | 2,916 | |||||
